Table: Taiko Pharmaceutical - 9-MTH group results

Taiko Pharmaceutical Co

11/11/2025 06:34

Nov 11 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Sep 30, 2025        Sep 30, 2024     Dec 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             4.23                4.58             6.30     
                 (-7.6 pct)          (+3.7 pct)       (+0.1 pct)  
  Operating        324 mln             726 mln          300 mln   
                 (-55.3 pct)                          (-52.4 pct) 
  Recurring        325 mln             705 mln          300 mln   
                 (-53.9 pct)                          (-56.4 pct) 
  Net              669 mln             714 mln          580 mln   
                 (-6.3 pct)                           (-35.4 pct) 
  EPS             13.33 yen           14.24 yen        11.54 yen  
  Ann Div                                NIL                      
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL                      
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T